
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
---|---|---|---|---|---|---|
Revenue | $23.5B | $33.6B | $44.2B | $35.8B | $39B | |
Revenue Growth (YoY) | -3.06% | 42.65% | 31.68% | -18.96% | 8.77% | |
Cost of Revenues | $9.3B | $14.3B | $18.6B | $15.9B | $17.1B | |
Gross Profit | $14.3B | $19.3B | $25.6B | $20B | $21.9B | |
Gross Profit Margin | 60.67% | 57.51% | 57.84% | 55.7% | 56.21% | |
R&D Expenses | $6B | $7.2B | $8.2B | $8.8B | $8.9B | |
Selling, General & Admin | $2.1B | $2.3B | $2.6B | $2.5B | $2.8B | |
Other Inc / (Exp) | -$90M | $961M | -$463M | $36M | $287M | |
Operating Expenses | $8B | $9.5B | $9.7B | $12.2B | $11.8B | |
Operating Income | $6.3B | $9.8B | $15.9B | $7.8B | $10.1B | |
Net Interest Expenses | $446M | $476M | $399M | $381M | $22M | |
EBT. Incl. Unusual Items | $5.7B | $10.3B | $15B | $7.4B | $10.3B | |
Earnings of Discontinued Ops. | -- | -- | -$50M | -$107M | $32M | |
Income Tax Expense | $521M | $1.2B | $2B | $104M | $226M | |
Net Income to Company | $5.2B | $9B | $13B | $7.3B | $10.1B | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $5.2B | $9B | $12.9B | $7.2B | $10.1B | |
Basic EPS (Cont. Ops) | $4.58 | $7.99 | $11.52 | $6.47 | $9.09 | |
Diluted EPS (Cont. Ops) | $4.52 | $7.87 | $11.37 | $6.42 | $8.97 | |
Weighted Average Basic Share | $1.1B | $1.1B | $1.1B | $1.1B | $1.1B | |
Weighted Average Diluted Share | $1.1B | $1.1B | $1.1B | $1.1B | $1.1B | |
EBITDA | $7.7B | $12.4B | $17.3B | $9.9B | $12.7B | |
EBIT | $6.3B | $10.8B | $15.5B | $8.1B | $11B | |
Revenue (Reported) | $23.5B | $33.6B | $44.2B | $35.8B | $39B | |
Operating Income (Reported) | $6.3B | $9.8B | $15.9B | $7.8B | $10.1B | |
Operating Income (Adjusted) | $6.3B | $10.8B | $15.5B | $8.1B | $11B |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $7.9B | $11.2B | $9.3B | $9.4B | $11B | |
Revenue Growth (YoY) | 52.13% | 40.69% | -16.92% | 1.23% | 16.94% | |
Cost of Revenues | $3.4B | $4.6B | $4.2B | $4.1B | $4.9B | |
Gross Profit | $4.5B | $6.5B | $5.1B | $5.3B | $6B | |
Gross Profit Margin | 56.75% | 58.37% | 55.22% | 56.27% | 55.03% | |
R&D Expenses | $1.8B | $2B | $2.2B | $2.2B | $2.2B | |
Selling, General & Admin | $557M | $624M | $614M | $707M | $706M | |
Other Inc / (Exp) | $82M | -$318M | -$75M | $170M | -$19M | |
Operating Expenses | $2.3B | $2.7B | $3B | $2.9B | $2.9B | |
Operating Income | $2.2B | $3.9B | $2.1B | $2.3B | $3.1B | |
Net Interest Expenses | $119M | $117M | $120M | $12M | -- | |
EBT. Incl. Unusual Items | $2.1B | $3.4B | $1.9B | $2.5B | $3.1B | |
Earnings of Discontinued Ops. | -- | -- | $2M | $51M | -- | |
Income Tax Expense | $367M | $489M | $193M | $223M | $293M | |
Net Income to Company | $1.8B | $2.9B | $1.7B | $2.3B | $2.8B | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $1.8B | $2.9B | $1.7B | $2.3B | $2.8B | |
Basic EPS (Cont. Ops) | $1.55 | $2.61 | $1.53 | $2.08 | $2.55 | |
Diluted EPS (Cont. Ops) | $1.53 | $2.57 | $1.52 | $2.06 | $2.52 | |
Weighted Average Basic Share | $1.1B | $1.1B | $1.1B | $1.1B | $1.1B | |
Weighted Average Diluted Share | $1.2B | $1.1B | $1.1B | $1.1B | $1.1B | |
EBITDA | $2.7B | $4B | $2.5B | $3.1B | $3.7B | |
EBIT | $2.3B | $3.6B | $2.1B | $2.7B | $3.3B | |
Revenue (Reported) | $7.9B | $11.2B | $9.3B | $9.4B | $11B | |
Operating Income (Reported) | $2.2B | $3.9B | $2.1B | $2.3B | $3.1B | |
Operating Income (Adjusted) | $2.3B | $3.6B | $2.1B | $2.7B | $3.3B |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $29.4B | $39.3B | $41.1B | $36.4B | $42.3B | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $11.8B | $16.3B | $17.9B | $16.1B | $18.7B | |
Gross Profit | $17.6B | $23B | $23.2B | $20.3B | $23.5B | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | $6.5B | $7.7B | $8.7B | $8.7B | $9B | |
Selling, General & Admin | $2.2B | $2.4B | $2.6B | $2.6B | $2.9B | |
Other Inc / (Exp) | $478M | $485M | -$322M | $612M | $80M | |
Operating Expenses | $8.7B | $10.2B | $10.5B | $12.1B | $12B | |
Operating Income | $8.9B | $12.8B | $12.7B | $8.2B | $11.5B | |
Net Interest Expenses | $497M | $474M | $396M | $187M | -- | |
EBT. Incl. Unusual Items | $8.9B | $12.8B | $12B | $8.6B | $11.6B | |
Earnings of Discontinued Ops. | -- | -- | -$86M | -$64M | $26M | |
Income Tax Expense | $885M | $1.7B | $1.3B | $187M | $600M | |
Net Income to Company | $8B | $11.2B | $10.6B | $8.5B | $11B | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $8B | $11.2B | $10.5B | $8.4B | $11B | |
Basic EPS (Cont. Ops) | $7.08 | $9.91 | $9.40 | $7.51 | $9.94 | |
Diluted EPS (Cont. Ops) | $6.97 | $9.77 | $9.32 | $7.44 | $9.82 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | $11B | $15B | $14.3B | $11.1B | $14B | |
EBIT | $9.5B | $13.4B | $12.5B | $9.3B | $12.3B | |
Revenue (Reported) | $29.4B | $39.3B | $41.1B | $36.4B | $42.3B | |
Operating Income (Reported) | $8.9B | $12.8B | $12.7B | $8.2B | $11.5B | |
Operating Income (Adjusted) | $9.5B | $13.4B | $12.5B | $9.3B | $12.3B |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $16.2B | $21.9B | $18.7B | $19.3B | $22.6B | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $6.9B | $9B | $8.2B | $8.4B | $10.1B | |
Gross Profit | $9.2B | $12.9B | $10.5B | $10.9B | $12.6B | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | $3.4B | $4B | $4.5B | $4.3B | $4.4B | |
Selling, General & Admin | $1.1B | $1.2B | $1.2B | $1.3B | $1.4B | |
Other Inc / (Exp) | $280M | -$195M | -$54M | $233M | $55M | |
Operating Expenses | $4.6B | $5.2B | $6B | $5.6B | $5.9B | |
Operating Income | $4.7B | $7.7B | $4.6B | $5.3B | $6.7B | |
Net Interest Expenses | $239M | $239M | $235M | $41M | -- | |
EBT. Incl. Unusual Items | $4.7B | $7.3B | $4.3B | $5.5B | $6.7B | |
Earnings of Discontinued Ops. | -- | -- | -$36M | $7M | -- | |
Income Tax Expense | $516M | $955M | $291M | $374M | $748M | |
Net Income to Company | $4.2B | $6.3B | $4B | $5.1B | $6B | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $4.2B | $6.3B | $3.9B | $5.1B | $6B | |
Basic EPS (Cont. Ops) | $3.71 | $5.63 | $3.52 | $4.56 | $5.41 | |
Diluted EPS (Cont. Ops) | $3.65 | $5.55 | $3.50 | $4.52 | $5.35 | |
Weighted Average Basic Share | $2.3B | $2.2B | $2.2B | $2.2B | $2.2B | |
Weighted Average Diluted Share | $2.3B | $2.3B | $2.3B | $2.3B | $2.2B | |
EBITDA | $5.8B | $8.4B | $5.5B | $6.7B | $7.9B | |
EBIT | $5B | $7.6B | $4.6B | $5.8B | $7.1B | |
Revenue (Reported) | $16.2B | $21.9B | $18.7B | $19.3B | $22.6B | |
Operating Income (Reported) | $4.7B | $7.7B | $4.6B | $5.3B | $6.7B | |
Operating Income (Adjusted) | $5B | $7.6B | $4.6B | $5.8B | $7.1B |
Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $6.7B | $7.1B | $2.8B | $8.5B | $7.8B | |
Short Term Investments | $4.5B | $5.3B | $3.6B | $2.9B | $5.5B | |
Accounts Receivable, Net | $2.7B | $2.2B | $4.2B | $1.9B | $2.3B | |
Inventory | $2.6B | $3.2B | $6.3B | $6.4B | $6.4B | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | $704M | $854M | $1.6B | $1.2B | $1.6B | |
Total Current Assets | $18.5B | $20.1B | $20.7B | $22.5B | $25.2B | |
Property Plant And Equipment | $3.7B | $4.6B | $5.2B | $5B | $4.7B | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | $6.3B | $7.2B | $10.5B | $10.6B | $10.8B | |
Other Intangibles | $1.7B | $1.5B | $1.9B | $1.4B | $1.2B | |
Other Long-Term Assets | $4B | $6.3B | $8.9B | $8.2B | $8.1B | |
Total Assets | $35.6B | $41.2B | $49B | $51B | $55.2B | |
Accounts Payable | $2.2B | $2.8B | $3.8B | $1.9B | $2.6B | |
Accrued Expenses | $2.5B | $3.1B | $1.5B | $1.7B | $1.8B | |
Current Portion Of Long-Term Debt | -- | $1.5B | $1.4B | $914M | $1.4B | |
Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
Other Current Liabilities | $2.3B | $2.6B | $3.6B | $3.1B | $3.3B | |
Total Current Liabilities | $8.7B | $12B | $11.9B | $9.6B | $10.5B | |
Long-Term Debt | $15.2B | $13.7B | $13.5B | $14.5B | $13.3B | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $29.5B | $31.3B | $31B | $29.5B | $28.9B | |
Common Stock | $586M | -- | $195M | $490M | -- | |
Other Common Equity Adj | $207M | $128M | -$22M | $358M | $587M | |
Common Equity | $6.1B | $10B | $18B | $21.6B | $26.3B | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $6.1B | $10B | $18B | $21.6B | $26.3B | |
Total Liabilities and Equity | $35.6B | $41.2B | $49B | $51B | $55.2B | |
Cash and Short Terms | $11.2B | $12.4B | $6.4B | $11.3B | $13.3B | |
Total Debt | $15.7B | $15.7B | $15.5B | $15.4B | $14.6B |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $6B | $7.2B | $3.5B | $9.2B | $7.2B | |
Short Term Investments | $5.5B | $4.4B | $3.2B | $4.6B | $6.6B | |
Accounts Receivable, Net | $3.3B | $4.1B | $3.7B | $3.1B | $3.7B | |
Inventory | $2.7B | $4.6B | $6.9B | $6.1B | $6.2B | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | $759M | $1.4B | $1B | $1.2B | $2.3B | |
Total Current Assets | $18.3B | $21.6B | $19.1B | $24.2B | $26.1B | |
Property Plant And Equipment | $4.2B | $4.9B | $5.3B | $4.7B | $4.4B | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | $7.2B | $7.3B | $10.6B | $10.8B | $10.9B | |
Other Intangibles | $1.7B | $1.3B | $1.7B | $1.3B | $1.2B | |
Other Long-Term Assets | $4.5B | $7.7B | $9.2B | $8.1B | $7B | |
Total Assets | $37.2B | $44.3B | $48.4B | $53.2B | $55.4B | |
Accounts Payable | $2.5B | $3.7B | $1.4B | $2.3B | $2.5B | |
Accrued Expenses | $994M | $1.1B | $1.2B | $1.3B | $1.2B | |
Current Portion Of Long-Term Debt | -- | $3B | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
Other Current Liabilities | $4.4B | $4.6B | $4.4B | $3.3B | $4.2B | |
Total Current Liabilities | $9.1B | $13.4B | $7.9B | $9.1B | $9.5B | |
Long-Term Debt | $15.2B | $12.2B | $15.5B | $14.5B | $13.3B | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $29.7B | $31B | $28.7B | $28.7B | $27.6B | |
Common Stock | -- | -- | -- | $66M | -- | |
Other Common Equity Adj | $281M | $215M | $418M | $438M | $395M | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $7.4B | $13.3B | $19.7B | $24.5B | $27.7B | |
Total Liabilities and Equity | $37.2B | $44.3B | $48.4B | $53.2B | $55.4B | |
Cash and Short Terms | $11.5B | $11.5B | $6.7B | $13.9B | $13.8B | |
Total Debt | $15.7B | $15.7B | $16B | $15.5B | $14.6B |
Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $5.2B | $9B | $13B | $7.3B | $10.1B | |
Depreciation & Amoritzation | $1.4B | $1.6B | $1.8B | $1.8B | $1.7B | |
Stock-Based Compensation | $1.2B | $1.7B | $2B | $2.5B | $2.6B | |
Change in Accounts Receivable | -$1.5B | $426M | -$2.1B | $2.5B | -$768M | |
Change in Inventories | -$1.2B | -$622M | -$3.1B | $8M | $13M | |
Cash From Operations | $5.8B | $10.5B | $9.1B | $11.3B | $12.2B | |
Capital Expenditures | $1.4B | $1.9B | $2.3B | $1.5B | $1B | |
Cash Acquisitions | -$185M | -$1.4B | -$4.9B | -$235M | -$254M | |
Cash From Investing | -$5.3B | -$3.4B | -$5.8B | $762M | -$3.6B | |
Dividends Paid (Ex Special Dividend) | -$2.9B | -$3B | -$3.2B | -$3.5B | -$3.7B | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $4.8B | $2.9B | $8.5B | $6.9B | $799M | |
Long-Term Debt Repaid | -$5.1B | -$2.9B | -$8.9B | -$7B | -$1.7B | |
Repurchase of Common Stock | -$2.5B | -$3.4B | -$3.1B | -$3B | -$4.1B | |
Other Financing Activities | -$475M | -$772M | -$800M | -$540M | -$949M | |
Cash From Financing | -$5.7B | -$6.8B | -$7.2B | -$6.7B | -$9.3B | |
Beginning Cash (CF) | $11.8B | $6.7B | $7.1B | $3.1B | $8.5B | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$5.2B | $382M | -$3.9B | $5.4B | -$690M | |
Ending Cash (CF) | $6.7B | $7.1B | $3.1B | $8.5B | $7.8B | |
Levered Free Cash Flow | $4.4B | $8.6B | $6.8B | $9.8B | $11.2B |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $1.8B | $2.9B | $1.7B | $2.3B | $2.8B | |
Depreciation & Amoritzation | $387M | $428M | $470M | $411M | $397M | |
Stock-Based Compensation | $422M | $498M | $628M | $705M | $702M | |
Change in Accounts Receivable | $799M | -$47M | $270M | $417M | -$165M | |
Change in Inventories | -$122M | -$699M | $80M | $163M | $91M | |
Cash From Operations | $2.9B | $2.7B | $1.5B | $3.6B | $2.6B | |
Capital Expenditures | $483M | $491M | $453M | $184M | $214M | |
Cash Acquisitions | -$1.1B | -$50M | -$32M | -$105M | -$81M | |
Cash From Investing | -$1.8B | -$526M | -$224M | -$939M | -$1.3B | |
Dividends Paid (Ex Special Dividend) | -$734M | -$764M | -$834M | -$895M | -$938M | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | $760M | $752M | $3.2B | $399M | -- | |
Long-Term Debt Repaid | -$761M | -$752M | -$4.2B | -$399M | -- | |
Repurchase of Common Stock | -$1.5B | -$951M | -$903M | -$731M | -$1.7B | |
Other Financing Activities | -$61M | -$70M | -$89M | -$149M | -$296M | |
Cash From Financing | -$2.1B | -$1.6B | -$2.5B | -$1.6B | -$2.8B | |
Beginning Cash (CF) | $7.1B | $6.6B | $5.1B | $8.2B | $8.7B | |
Foreign Exchange Rate Adjustment | -$12M | -$8M | $19M | -$10M | $6M | |
Additions / Reductions | -$1.1B | $574M | -$1.3B | $1B | -$1.5B | |
Ending Cash (CF) | $6B | $7.2B | $3.8B | $9.2B | $7.2B | |
Levered Free Cash Flow | $2.4B | $2.2B | $1B | $3.4B | $2.3B |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $8B | $11.2B | $10.6B | $8.5B | $11B | |
Depreciation & Amoritzation | $1.5B | $1.7B | $1.8B | $1.8B | $1.7B | |
Stock-Based Compensation | $1.4B | $1.8B | $2.3B | $2.5B | $2.8B | |
Change in Accounts Receivable | -$264M | -$733M | $399M | $600M | -$633M | |
Change in Inventories | -$920M | -$1.9B | -$2.2B | $732M | -$113M | |
Cash From Operations | $9.7B | $9.2B | $8.9B | $13.3B | $12.8B | |
Capital Expenditures | $1.7B | $2B | $2B | $997M | $1.1B | |
Cash Acquisitions | -$1.3B | -$429M | -$4.7B | -$339M | -$430M | |
Cash From Investing | -$6.5B | -$960M | -$5.5B | -$1.1B | -$3.4B | |
Dividends Paid (Ex Special Dividend) | -$2.9B | -$3.1B | -$3.4B | -$3.6B | -$3.8B | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $5.3B | $2.8B | $13.6B | $1.2B | $500M | |
Long-Term Debt Repaid | -$5.5B | -$2.8B | -$13.5B | -$1.7B | -$1.4B | |
Repurchase of Common Stock | -$2.1B | -$3.5B | -$3.2B | -$2.3B | -$6.1B | |
Other Financing Activities | -$712M | -$821M | -$602M | -$676M | -$1.1B | |
Cash From Financing | -$5.6B | -$7.1B | -$6.7B | -$6.7B | -$11.4B | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$2.5B | $1.2B | -$3.3B | $5.4B | -$2B | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | $8B | $7.2B | $6.9B | $12.3B | $11.7B |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $4.2B | $6.3B | $4B | $5.1B | $6B | |
Depreciation & Amoritzation | $751M | $834M | $868M | $848M | $833M | |
Stock-Based Compensation | $814M | $994M | $1.3B | $1.3B | $1.5B | |
Change in Accounts Receivable | $658M | -$501M | $2B | $92M | $227M | |
Change in Inventories | -$60M | -$1.3B | -$396M | $328M | $202M | |
Cash From Operations | $6.1B | $4.8B | $4.6B | $6.5B | $7.1B | |
Capital Expenditures | $952M | $1.1B | $851M | $398M | $491M | |
Cash Acquisitions | -$1.2B | -$288M | -$61M | -$165M | -$341M | |
Cash From Investing | -$3B | -$638M | -$357M | -$2.2B | -$2B | |
Dividends Paid (Ex Special Dividend) | -$1.5B | -$1.5B | -$1.7B | -$1.8B | -$1.9B | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | $1.6B | $1.5B | $6.5B | $799M | $500M | |
Long-Term Debt Repaid | -$1.6B | -$1.5B | -$6.1B | -$799M | -$500M | |
Repurchase of Common Stock | -$2B | -$2.1B | -$2.2B | -$1.5B | -$3.5B | |
Other Financing Activities | -$524M | -$573M | -$375M | -$511M | -$612M | |
Cash From Financing | -$3.8B | -$4B | -$3.6B | -$3.6B | -$5.8B | |
Beginning Cash (CF) | $13.8B | $13.7B | $8.2B | $16.7B | $16.6B | |
Foreign Exchange Rate Adjustment | $29M | -$16M | $46M | $5M | -$38M | |
Additions / Reductions | -$736M | $73M | $637M | $687M | -$608M | |
Ending Cash (CF) | $13.1B | $13.8B | $8.9B | $17.4B | $15.9B | |
Levered Free Cash Flow | $5.1B | $3.7B | $3.7B | $6.1B | $6.7B |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.